Navigation Links
Echo Therapeutics Initiates Clinical Study of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
Date:7/1/2008

FRANKLIN, Mass., July 1 /PRNewswire-FirstCall/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE) announced today that it has initiated a clinical study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System (tCGM System) in patients with Type 1 and Type 2 diabetes. The Company expects to complete and announce the results of the study in the third quarter of 2008. Echo's non-invasive Symphony tCGM System consists of its Prelude(TM) SkinPrep System, which incorporates patented and leading-edge skin permeation control technology, and wireless transmission and proprietary transdermal biosensor technologies. Echo's Symphony tCGM System is designed to provide both diabetes and hospital patients with a reliable, needle-free, easy-to-use, affordable and comfortable-to-wear continuous glucose monitoring device.

"Building on the momentum generated from our prior four positive pilot clinical studies, we are excited to have started our next pilot study in the important diabetes home use market. Our new Prelude Skin Prep System is a competitively unique component of our Symphony tCGM System, enabling our system to generate painless, needle-free, continuous glucose measurements. The primary purpose of this new study is to evaluate the performance of our Symphony tCGM System with Prelude as the new skin permeation element," stated Patrick T. Mooney, M.D., Echo's Chairman and Chief Executive Officer. "We are very excited about our significant development progress thus far, and we look forward to making additional progress with Symphony throughout 2008."

Echo's pilot clinical study will enroll ten (10) patients with diabetes (either Type 1 or Type 2) and will compare data obtained from its Symphony tCGM System with both the "gold standard" YSI Glucose Analyzer and a widely-used, commercially available "finger-stick" glucometer. The study will collect more than 900 data pairs to be used in the analyses. Reference glucose measurements will be mad
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Silence Therapeutics Announces Board Changes
2. Halozyme Therapeutics Announces That Chemophase Meets Primary Endpoint in Phase I/IIa Clinical Trial
3. Data Presented at American Headache Societys Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics Tezampanel
4. TorreyPines Therapeutics to Host Webinar at 11 a.m. EDT Today on the Opportunity for Treating Chronic Pain, Migraine and Muscle Spasticity Through Inhibition of Neurotransmitter Glutamate
5. CV Therapeutics Announces Archives of Internal Medicine Publication of Study Showing 20 Percent of Heart Attack Patients in Premier Registry Experienced Angina at One Year
6. Pilot Therapeutics Announces Relaunch as Gene Smart(TM) Health
7. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
8. PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity
9. Duska Therapeutics Licenses Portfolio of Heart Failure Drugs From Duke and Johns Hopkins
10. Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
11. Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...swire-FirstCall/ -- In a series of new initiatives...ration (Nasdaq: HSKA ) ("Heska" or the "Company")...d website. The upgraded site is the result of sev... align the site with the company,s new brand image...www.newscom.com/cgi-bin/prnh/20000622/HESKALOGO ) ...
(Date:11/19/2009)...wswire-FirstCall/ -- The D e al magazine has n...red Corporate Dealmakers for the second consecutiv...ired Dealmaker in pharma/biotech for the most effe...es since January 2006. ,, Over the past decade,... focus on high-growth, innovation-driven businesse...
(Date:11/19/2009)...wswire/ -- Mach 7 Technologies, a global provide...ement solutions, and QStar Technologies have signe... archive solution through their common US distribu...leader in providing digital image distribution and...er the agreement, Data Distributing will be able t...
Breaking Medicine Technology:Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 2Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 3Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 4Arizona Medical Marijuana Policy Project Sponsors of 2010 Medical Marijuana Ballot Initiative in Arizona Cheer Obama Administration Action 59776 1California Hospitals Launch H1N1 Public Service Announcement Campaign 59771 1California Hospitals Launch H1N1 Public Service Announcement Campaign 59771 2Childrens blood lead levels linked to lower test scores 10422 1Childrens blood lead levels linked to lower test scores 10422 2
...announced that,the Company,s recently submitted IN... to initiate a multi-center clinical trial of TG10...highly selective JAK2 inhibitor in,January, 2008. ...presentations related to TG101348 will be made at ...007) by Company scientific staff and outside,acade...
...aceuticals, Inc. (Nasdaq: BCRX ) today provided a...nt program, Forodesine HCl Data to be Presented a...ne Duvic, M.D., Deputy Chair, Dermatology, The Uni...cheduled to present interim data,from the Phase I/...eatment,of patients with refractory cutaneous T-ce...
Other Medicine Technology:TargeGen Announces Planned Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients, and Presentations at ASH 2BioCryst Provides Forodesine HCl Update 2BioCryst Provides Forodesine HCl Update 3BioCryst Provides Forodesine HCl Update 4BioCryst Provides Forodesine HCl Update 5
(Date:11/20/2009)... /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals ...areholders will be held on Monday, December 21, 20...oval of two special resolutions. The first special...f all or substantially all of the assets of NUCRYS...asset purchase agreement dated November 10, 2009 a...
(Date:11/20/2009)...20 Rates of infection by...late October, but the pandemic flu virus continues...oups, including the elderly, according to a new re...X ), the world,s leading provider of diagnostic te...t recent Quest Diagnostics Health Trends(TM) Repor...
(Date:11/20/2009)...wswire-USNewswire/ -- The following is a statement...a Health Care Association: ,, "The Nevada Healt...te Majority Leader Harry Reid for his leadership i...of protecting every Nevada seniors, ongoing access...strength and viability of our state,s vital frontl...
(Date:11/20/2009)...0, 2009Emergency medical service (EMS) providers i...rdiac arrests each year. Only 5 to 10 percent of ...tter quality cardiopulmonary resuscitation (CPR) p...ated with better patient outcome. The Resuscitati...al research network to study prehospital treatment...
(Date:11/20/2009)... is expected to continue, CDC says, , ,... the United States are seeing declines in H1N1 swi...iday, and while the disease remains widespread in ... last week. , "We are beginning to see some dec...t there is still a lot of influenza everywhere," D...
Breaking Medicine News(10 mins):Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Swine Flu Declining in Some Parts of U.S. 2Health News:Swine Flu Declining in Some Parts of U.S. 3
...it every 30 seconds, it rivals HIV and tuberculosi...t majority of its victims are under five years old...nald Ross was awarded the Nobel Prize for finally ...e search for an effective vaccine. Malari...
...mer UN High Commissioner for Human Rights: 'Univer.... It is a human right. We cannot implement that hu...ed a worldwide movement led by women to make thi...world health day stem from a 1987 meeting of the W...
...the Bible, Paris Hilton has adopted yet another sp... jail bound socialite, who has to report to Los An..., was spotted wearing a T-shirt featuring a pictur...cent. Some pals feel that Hilton, who has ...
...ft drinks is in the making following revelations t...ands like Fanta and Pepsi Max has the ability to s...ious cell damage. For when parts of DNA ar...he safety of E211, known as sodium benzoate, a pre...
...say in how they quit are more likely to try kickin...new research at the University of Rochester . ...ociate professor of medicine at the University of ... plan leads to smokers who are more motivated to q...
...etes hits hard. Depression does, too. Together, th... patients fight back, a team of Ohio University Co...iversity researchers have put together a new appro... to test the effectiveness of a combination of exe...
Other Medicine News:Health News:Vaccine Hope for Malaria 2Health News:International Day Of Action For Women's Health - 2007 2Health News:International Day Of Action For Women's Health - 2007 3Health News:International Day Of Action For Women's Health - 2007 4Health News:Soft Drink Additive Could Cause Cell Damage 2Health News:Soft Drink Additive Could Cause Cell Damage 3Health News:Choice is a Key Element in Success for Smokers Who Want to Quit 2Health News:Study Tests Depression Treatment for Diabetes Patients 2Health News:Study Tests Depression Treatment for Diabetes Patients 3
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
Medicine Products: